CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment [Phase 2]
Summary
Phase 2 trial of ABX464 in HIV-infected patients treated with boosted protease inhibitors has completed, and results were posted on 2024-09-19.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abivax S.A. | Conditions: HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19